The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response rates with pembrolizumab in combination with rituximab in patients with relapsed follicular lymphoma: Interim results of an on open-label, phase II study.
 
Loretta J. Nastoupil
Honoraria - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; Pharmacyclics; TG Therapeutics
Research Funding - Abbvie; Celgene; Janssen Biotech; TG Therapeutics
Travel, Accommodations, Expenses - Janssen Biotech
 
Jason R. Westin
Consulting or Advisory Role - Celgene; Genentech/Abbvie; Kite, a Gilead company; Novartis; ProNAi; Spectrum Pharmaceuticals
Research Funding - Celgene; Genentech; Janssen; Karyopharm Therapeutics; ProNAi
 
Nathan Hale Fowler
No Relationships to Disclose
 
Michelle A. Fanale
Honoraria - Plexus; Research to Practice; Seagen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; MedImmune; Merck; Millennium; Molecular Templates; Novartis; Seagen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Plexus; Research to Practice; Spectrum Pharmaceuticals; Takeda
 
Felipe Samaniego
No Relationships to Disclose
 
Yasuhiro Oki
Honoraria - Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Meiji Seika Kaisha
Research Funding - Cell Medica; Curis; Infinity Pharmaceuticals; Janssen; Millennium; Novartis; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Dava Oncology
 
Chizobam Obi
No Relationships to Disclose
 
JingJing Cao
No Relationships to Disclose
 
Xiaoyun Cheng
No Relationships to Disclose
 
Man Chun John Ma
No Relationships to Disclose
 
Zhiqiang Wang
No Relationships to Disclose
 
Fuliang Chu
No Relationships to Disclose
 
Lei Feng
No Relationships to Disclose
 
Shouhao Zhou
No Relationships to Disclose
 
Richard Eric Davis
No Relationships to Disclose
 
Sattva Swarup Neelapu
Consulting or Advisory Role - Biovest; Celgene; Medivation; Merck Sharp & Dohme; XEME BioPharma
Speakers' Bureau - Dava Oncology; Dava Oncology
Research Funding - Acerta Pharma; Bristol-Myers Squibb; Celgene; Cellectis; CureTech; Kite, a Gilead company; Merck Sharp & Dohme; Pharmacyclics
Travel, Accommodations, Expenses - Dava Oncology; Dava Oncology